TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation
Authors
Keywords
-
Journal
European Journal of Pharmacology
Volume 955, Issue -, Pages 175883
Publisher
Elsevier BV
Online
2023-07-09
DOI
10.1016/j.ejphar.2023.175883
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma
- (2023) Lizhi Pang et al. Cell Reports
- Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis
- (2022) Haocheng Xian et al. BMC CANCER
- Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
- (2022) Wenjing Xuan et al. Cancer Immunology Research
- New insights into activation and function of the AMPK
- (2022) Gregory R. Steinberg et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Activation of the clock gene TIMELESS by H3k27 acetylation promotes colorectal cancer tumorigenesis by binding to Myosin-9
- (2021) Meng Cao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis
- (2021) Zijia Qin et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer
- (2020) Shan Zhang et al. Cell Death & Disease
- SphK1 promotes development of non‑small cell lung cancer through activation of STAT3
- (2020) Yuefeng Ma et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Proteomic analyses identify differentially expressed proteins and pathways between low-risk and high-risk subtypes of early-stage lung adenocarcinoma and their prognostic impacts
- (2020) Juntuo Zhou et al. MOLECULAR & CELLULAR PROTEOMICS
- Activation of AMPK suppresses S1P-induced airway smooth muscle cells proliferation and its potential mechanisms
- (2020) Yilin Pan et al. MOLECULAR IMMUNOLOGY
- Elongational stalling activates mitoribosome-associated quality control
- (2020) Nirupa Desai et al. SCIENCE
- SPHK1 is a novel target of metformin in ovarian cancer
- (2019) Peter C Hart et al. MOLECULAR CANCER RESEARCH
- Clock genes and cancer development in particular in endocrine tissues
- (2019) Anna Angelousi et al. ENDOCRINE-RELATED CANCER
- Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor
- (2019) Xuezhu Rong et al. Journal of Thoracic Oncology
- Current Approaches in NSCLC Targeting K-RAS and EGFR
- (2019) Veronica Aran et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer
- (2019) Jinhua Zhou et al. HUMAN GENE THERAPY
- Mitochondrial transcription and translation: overview
- (2018) Aaron R. D’Souza et al. Essays in Biochemistry
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions
- (2018) M. Rohini et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway
- (2018) Zhonghai Jin et al. Cancer Cell International
- The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy
- (2018) Xiangjin Zheng et al. PHARMACOLOGY & THERAPEUTICS
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells
- (2017) Lorenzo Bazzani et al. Oncotarget
- Activating transcription factor 3 promotes malignance of lung cancer cells in vitro
- (2017) Xuebing Li et al. Thoracic Cancer
- Sphingosine 1-Phosphate Activation of EGFR As a Novel Target for Meningitic Escherichia coli Penetration of the Blood-Brain Barrier
- (2016) Xiangru Wang et al. PLoS Pathogens
- Timeless Interacts with PARP-1 to Promote Homologous Recombination Repair
- (2015) Si Xie et al. MOLECULAR CELL
- ATF3 Activates Stat3 Phosphorylation through Inhibition of p53 Expression in Skin Cancer Cells
- (2014) Zhen-Feng Hao et al. Asian Pacific Journal of Cancer Prevention
- Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1
- (2014) Paulette M Tamashiro et al. Cancer Cell International
- Protumorigenic role of Timeless in hepatocellular carcinoma
- (2014) NAHLA ELGOHARY et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
- (2014) Yi-Long Wu et al. LANCET ONCOLOGY
- Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
- (2013) Z.-l. Zeng et al. CLINICAL CANCER RESEARCH
- Inhibition of Insulin-like Growth Factor-Binding Protein-3 Signaling through Sphingosine Kinase-1 Sensitizes Triple-Negative Breast Cancer Cells to EGF Receptor Blockade
- (2013) J. L. Martin et al. MOLECULAR CANCER THERAPEUTICS
- TIMELESSis overexpressed in lung cancer and its expression correlates with poor patient survival
- (2012) Kenya Yoshida et al. CANCER SCIENCE
- Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
- (2012) R. Rosa et al. CLINICAL CANCER RESEARCH
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma
- (2011) Jian Pan et al. Journal of Translational Medicine
- Gefitinib for the treatment of non-small-cell lung cancer
- (2010) Lynn Campbell et al. EXPERT OPINION ON PHARMACOTHERAPY
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More